|
1
|
Kaplan RM and Kronick RG: Marital status
and longevity in the United States population. J Epidemiol
Community Health. 60:760–765. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hu YR and Goldman N: Mortality
differentials by marital status: An international comparison.
Demography. 27:233–250. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kravdal O: The impact of marital status on
cancer survival. Soc Sci Med. 52:357–368. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aizer AA, Chen MH, McCarthy EP, Mendu ML,
Koo S, Wilhite TJ, Graham PL, Choueiri TK, Hoffman KE, Martin NE,
et al: Marital status and survival in patients with cancer. J Clin
Oncol. 31:3869–3876. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hellenthal NJ, Chamie K, Ramirez ML and
deVere White RW: Sociodemographic factors associated with
nephrectomy in patients with metastatic renal cell carcinoma. J
Urol. 181:1013–1019. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pruthi RS, Lentz AC, Sand M, Kouba E and
Wallen EM: Impact of marital status in patients undergoing radical
cystectomy for bladder cancer. World J Urol. 27:573–576. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Q, Gan L, Liang L, Li X and Cai S: The
influence of marital status on stage at diagnosis and survival of
patients with colorectal cancer. Oncotarget. 6:7339–7347.
2015.PubMed/NCBI
|
|
8
|
Abdollah F, Sun M, Thuret R, Abdo A,
Morgan M, Jeldres C, Shariat SF, Perrotte P, Montorsi F and
Karakiewicz PI: The effect of marital status on stage and survival
of prostate cancer patients treated with radical prostatectomy: A
population-based study. Cancer Causes Control. 22:1085–1095. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tyson MD, Andrews PE, Etzioni DA, Ferrigni
RG, Humphreys MR, Swanson SK and Castle EK: Marital status and
prostate cancer outcomes. Can J Urol. 20:6702–6706. 2013.PubMed/NCBI
|
|
10
|
Du KL, Bae K, Movsas B, Yan Y, Bryan C and
Bruner DW: Impact of marital status and race on outcomes of
patients enrolled in radiation therapy oncology group prostate
cancer trials. Support Care Cancer. 20:1317–1325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schiffmann J, Beyer B, Tennstedt P, Boehm
K, Mehring G, Schlomm T, Salomon G, Karakiewicz P and Graefen M:
Oncological outcome after radical prostatectomy: Marital status
does not make a difference. Int J Urol. 22:484–489. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang XD, Qian JJ, Bai DS, Li ZN, Jiang GQ
and Yao J: Marital status independently predicts pancreatic cancer
survival in patients treated with surgical resection: An analysis
of the SEER database. Oncotarget. 7:24880–24887. 2016.PubMed/NCBI
|
|
13
|
Sanda MG, Cadeddu JA, Kirkby E, Chen RC,
Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH,
Makarov DV, et al: Clinically localized prostate cancer:
AUA/ASTRO/SUO Guideline. Part I: Risk stratification, shared
decision making, and care options. J Urol. Dec 14–2017.(Epub ahead
of print).
|
|
14
|
Mottet N, Bellmunt J, Bolla M, Briers E,
Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau
S, et al: EAU-ESTRO-SIOG guidelines on prostate cancer. Part.
1:Screening, diagnosis, and local treatment with curative intent.
Eur Urol 71: 618–629. 2017.
|
|
15
|
Cornford P, Bellmunt J, Bolla M, Briers E,
De Santis M, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, et al:
EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: Treatment of
relapsing, metastatic, and castration-resistant prostate cancer.
Eur Urol. 71:630–642. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kravdal H and Syse A: Changes over time in
the effect of marital status on cancer survival. BMC Public Health.
11:8042011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jaffe DH, Manor O, Eisenbach Z and Neumark
YD: The protective effect of marriage on mortality in a dynamic
society. Ann Epidemiol. 17:540–547. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fritz A, Percy C, Jack A, Shanmugaratnam
K, Sobin L, Parkin DM and Whelan S: International Classification of
Diseases for Oncology. 3rd. World Health Organization; Geneva:
2000
|
|
20
|
Tefilli MV, Gheiler EL, Tiguert R, Sakr W,
Grignon DJ, Banerjee M, Pontes JE and Wood DP Jr: Should Gleason
score 7 prostate cancer be considered a unique grade category?
Urology. 53:372–377. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ohno Y, Ohori M, Nakashima J, Okubo H,
Satake N, Hashimoto T and Tachibana M: Association between
preoperative serum total cholesterol level and biochemical
recurrence in prostate cancer patients who underwent radical
prostatectomy. Mol Clin Oncol. 4:1073–1077. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Denberg TD, Beaty BL, Kim FJ and Steiner
JF: Marriage and ethnicity predict treatment in localized prostate
carcinoma. Cancer. 103:1819–1825. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Denberg TD, Glodé LM, Steiner JF, Crawford
ED and Hoffman RM: Trends and predictors of aggressive therapy for
clinical locally advanced prostate carcinoma. BJU Int. 98:335–340.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaiser NC, Hartoonian N and Owen JE:
Toward a cancer-specific model of psychological distress:
Population data from the 2003–2005 National Health Interview
Surveys. J Cancer Surviv. 4:291–302. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
DiMatteo MR, Lepper HS and Croghan TW:
Depression is a risk factor for noncompliance with medical
treatment: Meta-analysis of the effects of anxiety and depression
on patient adherence. Arch Intern Med. 160:2101–2107. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Forsythe LP, Alfano CM, Kent EE, Weaver
KE, Bellizzi K, Arora N, Aziz N, Keel G and Rowland JH: Social
support, self-efficacy for decision-making, and follow-up care use
in long-term cancer survivors. Psychooncology. 23:788–796. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gidron Y and Ronson A: Psychosocial
factors, biological mediators, and cancer prognosis: A new look at
an old story. Curr Opin Oncol. 20:386–392. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Garssen B: Psychological factors and
cancer development: Evidence after 30 years of research. Clin
Psychol Rev. 24:315–338. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Levy SM, Herberman RB, Whiteside T, Sanzo
K, Lee J and Kirkwood J: Perceived social support and tumor
estrogen/progesterone receptor status as predictors of natural
killer cell activity in breast cancer patients. Psychosom Med.
52:73–85. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Antoni MH, Lutgendorf SK, Cole SW, Dhabhar
FS, Sephton SE, McDonald PG, Stefanek M and Sood AK: The influence
of bio-behavioural factors on tumour biology: Pathways and
mechanisms. Nat Rev Cancer. 6:240–248. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang M, Kenfield SA, Van Blarigan EL,
Batista JL, Sesso HD, Ma J, Stampfer MJ and Chavarro JE: Dietary
patterns after prostate cancer diagnosis in relation to
disease-specific and total mortality. Cancer Prev Res (Phila).
8:545–551. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kenfield SA, DuPre N, Richman EL, Stampfer
MJ, Chan JM and Giovannucci EL: Mediterranean diet and prostate
cancer risk and mortality in the health professionals follow-up
study. Eur Urol. 65:887–894. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fossati N, Nguyen DP, Trinh QD, Sammon J,
Sood A, Larcher A, Guazzoni G, Montorsi F, Briganti A, Menon M and
Abdollah F: The impact of insurance status on tumor characteristics
and treatment selection in contemporary patients with prostate
cancer. J Natl Compr Canc Netw. 13:1351–1358. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mahal BA, Aizer AA, Ziehr DR, Hyatt AS,
Lago-Hernandez C, Chen YW, Choueiri TK, Hu JC, Sweeney CJ, Beard
CJ, et al: The association between insurance status and prostate
cancer outcomes: Implications for the affordable care act. Prostate
Cancer Prostatic Dis. 17:273–279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Polesel J, Gini A, Dal Maso L, Stocco C,
Birri S, Taborelli M, Serraino D and Zucchetto A: The impact of
diabetes and other metabolic disorders on prostate cancer
prognosis. J Diabetes Complications. 30:591–596. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Armenian SH, Xu L, Ky B, Sun C, Farol LT,
Pal SK, Douglas PS, Bhatia S and Chao C: Cardiovascular disease
among survivors of Adult-onset cancer: A community-based
retrospective cohort study. J Clin Oncol. 34:1122–1130. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zist A, Amir E, Ocana AF and Seruga B:
Impact of comorbidity on the outcome in men with advanced prostate
cancer treated with docetaxel. Radiol Oncol. 49:402–408. 2015.
View Article : Google Scholar : PubMed/NCBI
|
